Cyclophosphamide Monohydrate
规格
6055-19-2CAS 号
629-456-4EC 号
N,N-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine;hydrateIUPAC 名称
C7H17Cl2N2O3P化学式
279.1 g/mol分子量
Cyclophosphamide monohydrate; 6055-19-2; Cyclophosphamide hydrate; DTXSID6024888; Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester monohydrate; 1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridine monohydrate; 2-(Bis(2-chloroethyl)amino)-1-oxa-3-aza-2-phosphocyclohexane 2-oxide monohydrate; 2-(Di(2-chloroethyl)amino)-1-oxa-3-aza-2-phosphacyclohexane-2-oxide monohydrate; (Bis(chloro-2-ethyl)amino)-2-tetrahydro-3,4,5,6-oxazaphosphorine-1,3,2-oxide-2 monohydrate; N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxaphosphorin-2-amine, 2-oxide monohydrate; N,N-Bis(beta-chloroethyl)-N',O-trimethylenephosphoric acid ester diamide monohydrate; CHEBI:4026; DTXCID604888; N,N-Bis(beta-chloroethyl)-N',O-propylenephosphoric acid ester amide monohydrate; (+-)-2-(Bis(2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide monohydrate; 2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, monohydrate; Cyclic N',O-propylene ester of N,N-bis(2-chloroethyl)phosphorodiamidic acid monohydrate; N,N-Di(2-chloroethyl)amino-N,O-propylene phosphoric acid ester diamide monohydrate; RefChem:919427; Cyclophosphamid monohydrate; 2H-1,3,2-Oxazaphosphorine, 2-(bis(2-chloroethyl)amino)tetrahydro-, 2-oxide, monohydrate; 629-456-4; N,N-Bis(2-Chloroethyl)-3,4,5,6-tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide monohydrate; 2-(Bis(2-chloroethyl)amino)-1,3,2-oxazaphosphinane 2-oxide hydrate; 2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide monohydrate; MFCD00149395; Cyclophosphamide (hydrate); MLS001306483; N,N-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine;hydrate; Cytoxan (TN); Ciclophosphamide hydrat; 2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide; Cytoxan hydrate; Cyclophosphamide (hydrated); CAS-6055-19-2; CCRIS 7469; 6055-19-2 (hydrate); NCGC00015209-05; UNII-8N3DW7272P; Prestwick_137; Cyclophosphamide CRS; Neosar (TN); Cyclophosphamide [USP:INN:BAN:JAN]; Cyclophosphamide (USP); Cyclophosphamide hydrate?; Cyclophosphamide?Monohydrate; N,N-Bis(beta-cloraethyl) N'-O-propylenphosphorildiamid monohydratum [Romanian]; SCHEMBL6071; CYCLOPHOSPHAMIDE [MI]; SPECTRUM1500213; CYCLOPHOSPHAMIDE [IARC]; orb1310365; orb3141189; CYCLOPHOSPHAMIDE [VANDF]; CHEMBL1200796; CYCLOPHOSPHANUM [WHO-IP]; Cyclophosphamide hydrate (JP18); HMS500M08; MSK10121W; CYCLOPHOSPHAMIDE [USP-RS]; CYCLOPHOSPHAMIDE [WHO-IP]; GLXC-10416; HMS1920C04; HMS2091I12; HMS2234I13; HMS3259P15; HMS3370O11; HMS5080L21; HY-17420AR; Tox21_110100; Tox21_201503; Tox21_300529; CCG-40013; EBC-11023; HY-17420A; N,N-Bis(beta-cloraethyl) N'-O-propylenphosphorildiamid monohydratum; s2057; CYCLOPHOSPHAMIDE [ORANGE BOOK]; CYCLOPHOSPHAMIDE HYDRATE [JAN]; AKOS009144593; Cyclophosphamide (hydrate) (Standard); Tox21_110100_1; AC-1741; CS-5005; CYCLOPHOSPHAMIDE [EP MONOGRAPH]; NC00662; 2H-1,3,2-Oxazaphosphorine, tetrahydro-2-(bis(2-chloroethyl)amino)-, 2-oxide, monohydrate; CYCLOPHOSPHAMIDE [USP MONOGRAPH]; CYCLOPHOSPHAMIDUM [WHO-IP LATIN]; Cyclophosphamide monohydrate, ISOPAC(R); NCGC00015209-11; NCGC00091741-01; NCGC00091741-04; NCGC00094636-01; NCGC00094636-02; NCGC00094636-03; NCGC00094636-04; NCGC00180900-01; NCGC00254543-01; NCGC00259054-01; 2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, monohydrate, (+-); AS-13677; Cyclophosphamide monohydrate, bulk package; SMR000718805; Cyclophosphamide monohydrate [EP monograph]; DB-053644; C9609; CYCLOPHOSPHAMIDE MONOHYDRATE [WHO-DD]; NS00078376; SW199628-3; EN300-52512; C06933; D00287; Cyclophosphamide monohydrate, analytical standard; F358374; SR-01000075737-4; Q27106287; 2-(Bis(2-chloroethyl)amino)-1,3,2-oxazaphosphinane2-oxidehydrate; 2-[Bis(2-chloroethyl)amino]-1,3,2-oxazaphosphinan-2-one hydrate; Cyclophosphamide, European Pharmacopoeia (EP) Reference Standard; 2-[bis(2-chloroethyl)amino]-1,3,2lambda5-oxazaphosphinan-2-one hydrate; Cyclophosphamide, United States Pharmacopeia (USP) Reference Standard; N,N-bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide hydrate; 2-[Bis(2-chloroethyl)amino]-1,3,2lambda~5~-oxazaphosphinan-2-one--water (1/1); Cyclophosphamide, Pharmaceutical Secondary Standard; Certified Reference Material; N,N-bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide--water (1/1); (+/-)-2-(BIS(2-CHLOROETHYL)AMINO)TETRAHYDRO-2H-1,3,2-OXAZAPHOSPHORINE 2-OXIDE MONOHYDRATE; 2H-1,3,2-OXAZAPHOSPHORIN-2-AMINE, N,N-BIS(2-CHLOROETHYL)TETRAHYDRO-, 2-OXIDE, MONOHYDRATE, (+/-)-同义词
含有Cyclophosphamide Monohydrate的产品
CICLOFOSFAMIDA SEACROSS 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFGCICLOFOSFAMIDA SEACROSS 1.000 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFGCICLOFOSFAMIDA HIKMA 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFGCICLOFOSFAMIDA HIKMA 200 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFGCICLOFOSFAMIDA HIKMA 2 000 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFGCICLOFOSFAMIDA HIKMA 1 000 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFGCICLOFOSFAMIDA ACCORD 200 MG/ML CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSIONGENOXAL 50 mg COMPRIMIDOS RECUBIERTOSCICLOFOSFAMIDA DR. REDDYS 500 MG/ML CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSIONCYCLOPHOSPHAMIDE SANDOZ 500 mg, poudre pour solution injectable ou pour perfusionCYCLOPHOSPHAMIDE SANDOZ 1000 mg, poudre pour solution injectable ou pour perfusionCYCLOPHOSPHAMIDE REDDY PHARMA 500 mg/1 mL, solution à diluer pour solution injectable/pour perfusion
第 1/2 页
